Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VYNE Therapeutics Inc. | 115,239 | reported | 31 Dec 2025 | tx 47+1,411,973−49,853 |
| Foamix Pharmaceuticals Ltd. | 0 | reported | 09 Mar 2020 | tx 19+286,230−366,230 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Dec 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 2,448 | 0.58 USD | |
| 30 Sept 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 2,453 | 0.34 USD | |
| 30 Jun 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 2,453 | 1.65 USD | |
| 31 Mar 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 6,044 | 1.58 USD | |
| 21 Jan 2025 | GRANT_AWARD | VYNE Therapeutics Inc. | 230,000 | 0.00 USD | deriv |
| 31 Dec 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 4,857 | 3.35 USD | |
| 30 Sept 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 109 | 1.88 USD | |
| 01 Jul 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 138 | 1.92 USD | |
| 01 Apr 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 157 | 3.08 USD | |
| 02 Jan 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 157 | 2.28 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | deriv |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | deriv |
| 02 Oct 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,184 | 3.83 USD | |
| 30 Jun 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 151 | 4.10 USD | |
| 31 Mar 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 480 | 3.08 USD | |
| 31 Dec 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,720 | 0.15 USD | |
| 30 Sept 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,719 | 0.22 USD | |
| 30 Jun 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,719 | 0.39 USD | |
| 31 Mar 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 3,469 | 0.65 USD | |
| 17 Mar 2022 | GRANT_AWARD | VYNE Therapeutics Inc. | 75,000 | 0.00 USD | |
| 17 Mar 2022 | GRANT_AWARD | VYNE Therapeutics Inc. | 75,000 | 0.00 USD | deriv |
| 31 Dec 2021 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,250 | 1.02 USD | |
| 30 Sept 2021 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,480 | 1.39 USD |